Yahoo
Frankfurt - Delayed Quote EUR

Insmed Incorporated (IM8N.F)

103.46 +2.68 (+2.66%)
As of 8:02:14 AM GMT+1. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-595,622 -935,014 -683,882 -536,247 -400,439
Cash Flow from Investing Activities
543,796 -64,575 -583,175 -223,604 -34,584
Cash Flow from Financing Activities
114,189 954,073 1,341,020 168,439 793,273
Cash and Cash Equivalents, End of Period
396,563 510,445 555,030 482,374 1,074,036
Cash Flow, Supplemental
Free Cash Flow to Firm
-447,921.72 -829,533.95 -639,224.18 -450,074.76 -399,152.55
Capital Expenditure, Calculated
31,953 32,561 21,923 13,288 9,878
Issuance of Capital Stock
0 823,282 1,084,124 152,475 292,153
Repurchase of Capital Stock
0 0 0 0 0
12/31/2022 - 2/2/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: